Pragmatic randomised controlled trial of local corticosteroid injection and naproxen for treatment of lateral epicondylitis of elbow in primary care.

Staffordshire Rheumatology Centre, The Haywood, Burslem, Stoke on Trent ST6 7AG.
BMJ Clinical Research (Impact Factor: 14.09). 11/1999; 319(7215):964-8. DOI: 10.1136/bmj.319.7215.964
Source: PubMed

ABSTRACT To compare the clinical effectiveness of local corticosteroid injection, standard non-steroidal anti-inflammatory drugs, and simple analgesics for the early treatment of lateral epicondylitis in primary care.
Multicentre pragmatic randomised controlled trial.
23 general practices in North Staffordshire and South Cheshire.
164 patients aged 18-70 years presenting with a new episode of lateral epicondylitis. Interventions: Local injection of 20 mg methylprednisolone plus lignocaine, naproxen 500 mg twice daily for two weeks, or placebo tablets. All participants received a standard advice sheet and co-codamol as required.
Participants' global assessment of improvement (five point scale) at four weeks. Pain, function, and "main complaint" measured on 10 point Likert scales at 4 weeks, 6 months, and 12 months.
Over 2 years, 53 subjects were randomised to injection, 53 to naproxen, and 58 to placebo. Prognostic variables were similar between groups at baseline. At 4 weeks, 48 patients (92%) in the injection group were completely better or improved compared with 30 (57%) in the naproxen group (P<0.001) and 28 (50%) in the placebo group (P<0.001). At 12 months, 43 patients (84%) in the injection group had pain scores </=3 compared with 45 (85%) in the naproxen group and 44 (82%) in the placebo group (P>0.05).
Early local corticosteroid injection is effective for lateral epicondylitis. Outcome at one year was good in all groups, and effective early treatment does not seem to influence this.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Lateral epicondylitis is a painful tendinopathy for which several nonsurgical treatment strategies are used. Superiority of these nonsurgical treatments over nontreatment has not been definitively established.
    Clinical Orthopaedics and Related Research 10/2014; 473(3). DOI:10.1007/s11999-014-4022-y · 2.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Common extensor tendinopathy, or tennis elbow, is the most common cause of lateral elbow pain. While most cases are self-limiting, a percentage will become chronic and lead to substantive time away from work and sport. There is no clear consensus on timing and choice of modality for treatment. There are a multitude of treatment options available including watchful waiting, physical therapy, topical nitroglycerin, extracorporeal shockwave therapy, corticosteroid injection, prolotherapy, neovessel sclerosis, autologous growth factor injections, percutaneous needle tenotomy, and surgery. This article presents a comprehensive review of the current literature on the treatment of common extensor tendinopathy
    12/2014; 3(1). DOI:10.1007/s40141-014-0070-1
  • [Show abstract] [Hide abstract]
    ABSTRACT: Non-surgical approaches to treatment of lateral epicondylitis are numerous. The aim of this systematic review is to examine randomized, controlled trials of these treatments. Numerous databases were systematically searched from earliest records to February 2013. Search terms included "lateral epicondylitis," "lateral elbow pain," "tennis elbow," "lateral epicondylalgia," and "elbow tendinopathy" combined with "randomized controlled trial." Two reviewers examined the literature for eligibility via article abstract and full text. Fifty-eight articles met eligibility criteria: (1) a target population of patients with symptoms of lateral epicondylitis; (2) evaluation of treatment of lateral epicondylitis with the following non-surgical techniques: corticosteroid injection, injection technique, iontophoresis, botulinum toxin A injection, prolotherapy, platelet-rich plasma or autologous blood injection, bracing, physical therapy, shockwave therapy, or laser therapy; and (3) a randomized controlled trial design. Lateral epicondylitis is a condition that is usually self-limited. There may be a short-term pain relief advantage found with the application of corticosteroids, but no demonstrable long-term pain relief. Injection of botulinum toxin A and prolotherapy are superior to placebo but not to corticosteroids, and botulinum toxin A is likely to produce concomitant extensor weakness. Platelet-rich plasma or autologous blood injections have been found to be both more and less effective than corticosteroid injections. Non-invasive treatment methods such as bracing, physical therapy, and extracorporeal shockwave therapy do not appear to provide definitive benefit regarding pain relief. Some studies of low-level laser therapy show superiority to placebo whereas others do not. There are multiple randomized controlled trials for non-surgical management of lateral epicondylitis, but the existing literature does not provide conclusive evidence that there is one preferred method of non-surgical treatment for this condition. Lateral epicondylitis is a condition that is usually self-limited, resolving over a 12- to 18-month period without treatment. Therapeutic Level II. See Instructions to Authors for a complete description of level of evidence.
    Hand 12/2014; 9(4):419-446. DOI:10.1007/s11552-014-9642-x


1 Download
Available from